Sunrise gets vote of confidence from bank
This article was originally published in Clinica
US refractive surgery company Sunrise Technologies International has announced that its bank has given the company two more months'extension on its credit facility. The company has drastically reduced its costs and has seen its revenues rise rapidly this year, but is facing a cashflow problem. Its working capital diminished to just over $1 million at the end of the first quarter.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.